151 related articles for article (PubMed ID: 122160)
1. Valproic acid-phenytoin interaction.
Friel PN; Leal KW; Wilensky AJ
Ther Drug Monit; 1979; 1(2):243-8. PubMed ID: 122160
[TBL] [Abstract][Full Text] [Related]
2. Is free fraction measurement of phenytoin always necessary in pediatric epileptic patients?
Johno I; Kuzuya T; Suzuki K; Hasegawa M; Nakamura T; Kitazawa S; Aso K; Watanabe K
Ther Drug Monit; 1988; 10(1):39-44. PubMed ID: 3376180
[TBL] [Abstract][Full Text] [Related]
3. Nomogram for the prediction of unbound phenytoin concentrations in patients on a combined treatment of phenytoin and valproic acid.
May TW; Rambeck B; Nothbaum N
Eur Neurol; 1991; 31(1):57-60. PubMed ID: 2015840
[TBL] [Abstract][Full Text] [Related]
4. Effect of different doses of valproic acid on the serum levels of total and free diphenylhydantoin.
Alvarez N
Clin Electroencephalogr; 1985 Apr; 16(2):104-10. PubMed ID: 3924446
[TBL] [Abstract][Full Text] [Related]
5. Fluctuations of unbound and total phenytoin concentrations during the day in epileptic patients on valproic acid comedication.
May T; Rambeck B
Ther Drug Monit; 1990 Mar; 12(2):124-8. PubMed ID: 2107607
[TBL] [Abstract][Full Text] [Related]
6. Time-dependent interaction between phenytoin and valproic acid.
Riva R; Albani F; Contin M; Perucca E; Ambrosetto G; Gobbi G; Santucci M; Procaccianti G; Baruzzi A
Neurology; 1985 Apr; 35(4):510-5. PubMed ID: 3920548
[TBL] [Abstract][Full Text] [Related]
7. The effects of phenytoin and carbamazepine on serum concentrations of mono-unsaturated metabolites of valproic acid.
Kondo T; Otani K; Hirano T; Kaneko S; Fukushima Y
Br J Clin Pharmacol; 1990 Jan; 29(1):116-9. PubMed ID: 2105099
[TBL] [Abstract][Full Text] [Related]
8. Serial free and plasma valproic acid and phenytoin monitoring and drug interactions.
Haidukewych D; Rodin EA
Ther Drug Monit; 1981; 3(3):303-7. PubMed ID: 6798720
[TBL] [Abstract][Full Text] [Related]
9. Predicting unbound phenytoin concentrations in patients receiving valproic acid: a comparison of two prediction methods.
Kerrick JM; Wolff DL; Graves NM
Ann Pharmacother; 1995 May; 29(5):470-4. PubMed ID: 7655129
[TBL] [Abstract][Full Text] [Related]
10. Serum bilirubin levels with antiepileptic drugs.
Gough H; Goggin T; Crowley M; Callaghan N
Epilepsia; 1989; 30(5):597-602. PubMed ID: 2507305
[TBL] [Abstract][Full Text] [Related]
11. Drug interaction between phenytoin and valproic acid in a child with refractory epilepsy: a case report.
Carvalho IV; Carnevale RC; Visacri MB; Mazzola PG; de Fátima Lopes Ambrósio R; dos Reis MC; de Queiroz RA; Moriel P
J Pharm Pract; 2014 Apr; 27(2):214-6. PubMed ID: 24381240
[TBL] [Abstract][Full Text] [Related]
12. Serum concentrations and enzyme induction in epileptic children treated with phenytoin and valproate.
de Wolff FA; Peters AC; van Kempen GM
Neuropediatrics; 1982 Feb; 13(1):10-3. PubMed ID: 6123089
[TBL] [Abstract][Full Text] [Related]
13. Valproic acid: in vitro plasma protein binding and interaction with phenytoin.
Cramer JA; Mattson RH
Ther Drug Monit; 1979; 1(1):105-16. PubMed ID: 121944
[TBL] [Abstract][Full Text] [Related]
14. Serum protein binding of diphenylhydantoin in man. II. Interaction with sodium valproate in epileptic patients.
Gatti G; Lecchini S; Frigo GM; Visintini D; Calzetti S; Lombardi M; Cattaino G
Farmaco Prat; 1979 Jan; 34(1):46-8. PubMed ID: 378689
[No Abstract] [Full Text] [Related]
15. Effect of valproate on free plasma phenytoin concentrations.
Tsanaclis LM; Allen J; Perucca E; Routledge PA; Richens A
Br J Clin Pharmacol; 1984 Jul; 18(1):17-20. PubMed ID: 6430316
[TBL] [Abstract][Full Text] [Related]
16. Effects of anticonvulsants on plasma levels and entero-hepatic circulation of valproic acid and on hepatic drug metabolizing enzyme activities in rats.
Ogiso T; Ito Y; Iwaki M; Yoneda I; Horibe Y
J Pharmacobiodyn; 1989 May; 12(5):255-63. PubMed ID: 2509672
[TBL] [Abstract][Full Text] [Related]
17. Valproic acid and phenytoin effects on serum proteins and immunoglobulins of epileptic patients.
Garzón P; González-Cornejo S; Román-Maldonado S; Navarro-Ruiz A
Gen Pharmacol; 1985; 16(4):411-3. PubMed ID: 2412936
[TBL] [Abstract][Full Text] [Related]
18. Effect of single doses of sodium valproate on serum phenytoin levels and protein binding in epileptic patients.
Monks A; Richens A
Clin Pharmacol Ther; 1980 Jan; 27(1):89-95. PubMed ID: 6985856
[TBL] [Abstract][Full Text] [Related]
19. Valproate metabolites in high-dose valproate plus phenytoin therapy.
Sugimoto T; Muro H; Woo M; Nishida N; Murakami K
Epilepsia; 1996 Dec; 37(12):1200-3. PubMed ID: 8956852
[TBL] [Abstract][Full Text] [Related]
20. Derivation and evaluation of an equation for prediction of free phenytoin concentration in patients co-medicated with valproic acid.
Haidukewych D; Rodin EA; Zielinski JJ
Ther Drug Monit; 1989; 11(2):134-9. PubMed ID: 2497562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
